Defence Therapeutics Inc. (DTC.CN)
CAD 0.52
(0.0%)
CAD 0.52
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 90.92 Thousand | 13.82 Thousand | - | - | - | - |
| Gross Profit | -90.92 Thousand | -13.82 Thousand | - | - | - | - |
| Operating Expenses | 12.65 Million | 6.48 Million | 7.32 Million | 2.85 Million | 673.18 Thousand | 41.94 Thousand |
| Selling, General and Administrative Expenses | 8.79 Million | 2.89 Million | 3.55 Million | 1.7 Million | 239.73 Thousand | 41.94 Thousand |
| Research and Development Expenses | 3.86 Million | 3.58 Million | 3.76 Million | 1.15 Million | 433.45 Thousand | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 12.65 Million | 6.48 Million | 7.32 Million | 2.85 Million | 673.18 Thousand | 41.94 Thousand |
| Operating Income | -12.65 Million | -6.48 Million | -7273.82 | -2825.75 | -673.18 Thousand | -41.95 Thousand |
| Interest Expense | - | 262.93 Thousand | - | - | - | - |
| Income Tax Expense | - | 105 Thousand | 16.59 Thousand | -2859.25 | -434.12 Thousand | 40.00 |
| Earnings before Tax | -13.19 Million | -6.86 Million | -7.34 Million | -2.85 Million | -673.18 Thousand | -1946.00 |
| Net Income | -13.19 Million | -6.76 Million | -7.34 Million | -2.85 Million | -673.18 Thousand | -1946.00 |
| Earnings Per Share Basic | -0.30 | -0.17 | -0.20 | -0.11 | -0.02 | -0.00 |
| Earnings Per Share Diluted | -0.30 | -0.17 | -0.20 | -0.11 | -0.02 | -0.00 |
| Weighted Average Shares Outstanding | 44.63 Million | 39.66 Million | 36.07 Million | 26.59 Million | 34.79 Million | 34.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.63 Million | 39.66 Million | 36.07 Million | 26.59 Million | 34.79 Million | 34.79 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -12.67 Million | -6.48 Million | - | -2.85 Million | -673.18 Thousand | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 48.63 Thousand | 22.55 Thousand | 6948.00 | 12.78 Thousand | 13.82 Thousand | 789.00 |
| Gross Profit | -48.63 Thousand | -22.55 Thousand | -6948.00 | -12.78 Thousand | -13.82 Thousand | -789.00 |
| Operating Expenses | 1.18 Million | 1.18 Million | 8.3 Million | 2.11 Million | 6.53 Million | 1.72 Million |
| Selling, General and Administrative Expenses | 433.04 Thousand | 545.77 Thousand | 6.73 Million | 970.39 Thousand | - | 1.1 Million |
| Research and Development Expenses | 596.69 Thousand | 641.86 Thousand | 1.56 Million | 1.05 Million | - | 625.68 Thousand |
| Other Expenses | 159.02 Thousand | - | - | - | - | - |
| Cost and Expenses | 1.18 Million | 1.21 Million | 8.3 Million | 2.11 Million | 6.54 Million | 1.72 Million |
| Operating Income | -1.18 Million | -1.21 Million | -8.3 Million | -2.09 Million | -6.54 Million | -1.72 Million |
| Interest Expense | 148.96 Thousand | 94.85 Thousand | 58.07 Thousand | 95.95 Thousand | 262.93 Thousand | 103.48 Thousand |
| Income Tax Expense | 148.96 Thousand | -3.00 | 2.00 | 95.95 Thousand | -105 Thousand | -105 Thousand |
| Earnings before Tax | -1.34 Million | -1.32 Million | -8.31 Million | -2.19 Million | -6.86 Million | -1.83 Million |
| Net Income | -1.34 Million | -1.32 Million | -8.31 Million | -2.19 Million | -6.76 Million | -1.72 Million |
| Earnings Per Share Basic | -0.03 | -0.03 | -0.19 | -0.05 | - | -0.04 |
| Earnings Per Share Diluted | -0.03 | -0.03 | -0.19 | -0.05 | - | -0.04 |
| Weighted Average Shares Outstanding | 44.61 Million | 44.61 Million | 44.09 Million | 43.88 Million | 39.66 Million | 43.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.61 Million | 44.61 Million | 44.09 Million | 43.88 Million | 39.66 Million | 43.21 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.13 Million | -1.18 Million | -8.3 Million | -2.08 Million | - | -1.72 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
INDI
TRRE
SYV
000901
GGLXF
FHN-PC